ArticleBioinformation2025
Evaluation of oral mucositis severity and management in head and neck cancer patients undergoing radiotherapy: A prospective study.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Radiotherapy-Associated Pain in Head and Neck Cancer: From Clinical Burden to Neuroimmune Modulator.Journal of clinical medicine · 2026Review
- Pre-radiotherapy cachexia is associated with treatment discontinuation in patients with head and neck squamous cell carcinoma receiving definitive radiotherapy.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral mucositis is a frequent and debilitating side effect in patients undergoing radiotherapy for head and neck cancers, often leading to pain, nutritional compromise and treatment interruptions. A prospective observational research was conducted on 60 patients undergoing radiotherapy, with or without chemotherapy. 46.7% of patients developed Grade 3-4 mucositis. Severe mucositis was significantly associated with low BMI (p = 0.031), hemoglobin <11 g/dL (p = 0.007), tumor site (p = 0.016) and concurrent chemoradiotherapy (p = 0.001). Mucositis severity is influenced by nutritional and treatment-related factors. Early identification and targeted supportive interventions can improve clinical outcomes and reduce treatment disruptions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.